聚醇对围产期脑损伤的有效性:临床前研究的系统审查
Paula Brielle Pontes1,2, Ana Elisa Toscano2,3, Diego Cabral Lacerda2,3
1Postgraduate Program of Neuropsychiatry and Behavioral Sciences, Federal University of Pernambuco, Recife 50670-901, Pernambuco, Brazil.
Foods (Basel, Switzerland)
|June 28, 2023
概括
在生命早期服用多补充剂可能会减少因缺氧导致的脑损伤. 这种干预措施显示了通过调节炎症和氧化应激来改善运动和认知功能的潜力.
科学领域:
- 神经科学是一个神经科学.
- 发展生物学 发展生物学
- 营养科学 营养科学
背景情况:
- 早期的氧化压力和神经炎症导致终身损伤.
- 缺氧损伤,如脑,与这些早期的侮辱有关.
- 聚醇在缓解这些破坏性过程方面表现有前途.
研究的目的:
- 审查关于多补充剂对缺氧缺血性脑损伤的影响的临床前证据.
- 评估聚醇对形态,炎症和氧化参数的影响.
- 检查对运动和行为功能的影响.
主要方法:
- 临床前研究的系统审查.
- 对调查生命早期使用多的研究进行分析.
- 对形态,炎症,氧化,运动和行为结果的评估.
主要成果:
- 多补充剂可以减轻胚胎,胎儿,新生儿和后代受试者的脑损伤.
- 有证据表明适应性反应和表型可塑性的调节.
- 有益效应与通过AMPK,NF-κB和PI3K通路的表观遗传变化有关.
结论:
- 在生命早期给予多是一种潜在的治疗缺氧缺血性脑损伤的干预措施.
- 这种方法可以调节炎症和氧化应激,防止长期的功能缺陷.
- 进一步的研究支持多用于神经保护和功能恢复.
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...


